BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36656530)

  • 1. Method for Inclusion Bodies Production via E. coli Host System: rGCSF as Model Biotherapeutic Protein.
    Rani AK; Naira VR; Rathore AS
    Methods Mol Biol; 2023; 2617():249-256. PubMed ID: 36656530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refolding of Proteins Expressed as Inclusion Bodies in E. coli.
    Sharma R; Anupa A; Rathore AS
    Methods Mol Biol; 2023; 2617():201-208. PubMed ID: 36656526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pre-induction temperature affects recombinant HuGM-CSF aggregation in thermoinducible Escherichia coli.
    Restrepo-Pineda S; Sánchez-Puig N; Pérez NO; García-Hernández E; Valdez-Cruz NA; Trujillo-Roldán MA
    Appl Microbiol Biotechnol; 2022 Apr; 106(8):2883-2902. PubMed ID: 35412129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermoinducible E. coli for Recombinant Protein Production in Inclusion Bodies.
    Valdez-Cruz NA; Trujillo-Roldán MA
    Methods Mol Biol; 2023; 2617():17-30. PubMed ID: 36656514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant production of ESAT-6 antigen in thermoinducible Escherichia coli: the role of culture scale and temperature on metabolic response, expression of chaperones, and architecture of inclusion bodies.
    Restrepo-Pineda S; Bando-Campos CG; Valdez-Cruz NA; Trujillo-Roldán MA
    Cell Stress Chaperones; 2019 Jul; 24(4):777-792. PubMed ID: 31165436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleic acids in inclusion bodies obtained from E. coli cells expressing human interferon-gamma.
    Krachmarova E; Ivanov I; Nacheva G
    Microb Cell Fact; 2020 Jul; 19(1):139. PubMed ID: 32652996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting Escherichia coli as microbial factory for enhanced production of human serum albumin.
    Sharma A; Chaudhuri TK
    Microb Cell Fact; 2017 Oct; 16(1):173. PubMed ID: 28982367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active protein aggregates produced in Escherichia coli.
    Peternel S; Komel R
    Int J Mol Sci; 2011; 12(11):8275-87. PubMed ID: 22174663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teaching an old pET new tricks: tuning of inclusion body formation and properties by a mixed feed system in E. coli.
    Wurm DJ; Quehenberger J; Mildner J; Eggenreich B; Slouka C; Schwaighofer A; Wieland K; Lendl B; Rajamanickam V; Herwig C; Spadiut O
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):667-676. PubMed ID: 29159587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Solubilization and Refolding Buffers.
    Roufarshbaf M; Akbari V
    Methods Mol Biol; 2023; 2617():155-164. PubMed ID: 36656522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.
    Panda AK
    Adv Biochem Eng Biotechnol; 2003; 85():43-93. PubMed ID: 12930093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New properties of inclusion bodies with implications for biotechnology.
    Peternel S; Jevsevar S; Bele M; Gaberc-Porekar V; Menart V
    Biotechnol Appl Biochem; 2008 Apr; 49(Pt 4):239-46. PubMed ID: 17708747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion Bodies: Status Quo and Perspectives.
    Kopp J; Spadiut O
    Methods Mol Biol; 2023; 2617():1-13. PubMed ID: 36656513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli.
    Rinas U; Hoffmann F; Betiku E; Estapé D; Marten S
    J Biotechnol; 2007 Jan; 127(2):244-57. PubMed ID: 16945443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control of inclusion bodies in Escherichia coli.
    Jürgen B; Breitenstein A; Urlacher V; Büttner K; Lin H; Hecker M; Schweder T; Neubauer P
    Microb Cell Fact; 2010 May; 9():41. PubMed ID: 20509924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of Active Recombinant Hyaluronidase Inclusion Bodies from
    Schwaighofer A; Ablasser S; Lux L; Kopp J; Herwig C; Spadiut O; Lendl B; Slouka C
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioprocessing of recombinant proteins from
    Kachhawaha K; Singh S; Joshi K; Nain P; Singh SK
    Prep Biochem Biotechnol; 2023; 53(7):728-752. PubMed ID: 36534636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic transcriptional response of Escherichia coli to inclusion body formation.
    Baig F; Fernando LP; Salazar MA; Powell RR; Bruce TF; Harcum SW
    Biotechnol Bioeng; 2014 May; 111(5):980-99. PubMed ID: 24338599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives of inclusion bodies for bio-based products: curse or blessing?
    Slouka C; Kopp J; Spadiut O; Herwig C
    Appl Microbiol Biotechnol; 2019 Feb; 103(3):1143-1153. PubMed ID: 30569219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of recombinant Mycobacterium tuberculosis antigens fused with cell wall-anchoring motif (LysM) from inclusion bodies using non-denaturing reagent (N-laurylsarcosine).
    Mustafa AD; Kalyanasundram J; Sabidi S; Song AA; Abdullah M; Abdul Rahim R; Yusoff K
    BMC Biotechnol; 2019 May; 19(1):27. PubMed ID: 31088425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.